|
Mark E. Robitaille, President and CEO of Martin Health Systems; Mel Rothberg, Chief Operating Officer at VGTI Florida; and John D. Couris, President and CEO of Jupiter Medical Center. |
.jpg)
The Vaccine & Gene Therapy Institute of Florida (VGTI Florida™) has signed Affiliation Agreements with Martin Health System and Jupiter Medical Center to move forward with the beginnings of a new clinical trial consortium in South Florida.
In signing the Affiliation Agreements with both hospitals, VGTI Florida has honored part of their commitment to the Florida Innovation Incentive Fund, which assisted in funding of their new state-of-the-art facility.
Participation in this consortium is a strong movement forward into furthering South Florida’s positive reputation in the research and medical fields. VGTI Florida has hired a Medical Director to work with the Business Development group in attracting interest in sponsors and to oversee operations within the clinical trial consortium.
